MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 01-08-2026
Neogen Corporation Total Inventories 2011-2026 | NEOG
Annual Total Inventories Neogen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 191 M | 189 M | 134 M | 122 M | 101 M | 95.1 M | 86 M | 76 M | 73.1 M | 64.4 M | 51.6 M | 51.2 M | 38.3 M | 35 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 191 M | 35 M | 93.4 M |
Quarterly Total Inventories Neogen Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 163 M | 193 M | 191 M | 205 M | 198 M | 199 M | 189 M | 182 M | 161 M | 141 M | 134 M | 144 M | 136 M | 129 M | 122 M | 113 M | 107 M | 102 M | 101 M | 101 M | 92.5 M | 97.6 M | 95.1 M | 89.2 M | 86.4 M | 87.7 M | 86 M | 86 M | 79.5 M | 78.8 M | 76 M | 76 M | 73.7 M | 73.4 M | 73.1 M | 73.1 M | 71.7 M | 69.8 M | 64.4 M | 64.4 M | 61.5 M | 56.1 M | 51.6 M | 51.6 M | 53.5 M | 55.1 M | 51.2 M | 51.2 M | 47.3 M | 43.8 M | 38.3 M | 38.3 M | 38.4 M | 35 M | 35 M | 35 M | 36.4 M | 34.2 M | 32 M | 32 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 205 M | 32 M | 91.4 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
830 M | $ 114.25 | -1.07 % | $ 34.7 B |  USA |
 |
Biomerica
BMRA
|
1.49 M | $ 2.17 | - | $ 4.98 M | USA |
 |
BioNano Genomics
BNGO
|
7.83 M | $ 1.2 | -0.03 % | $ 6.53 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
123 M | $ 16.5 | 1.85 % | $ 178 M |  China |
 |
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | USA |
 |
CareDx, Inc
CDNA
|
26.7 M | $ 18.32 | 0.05 % | $ 976 M | USA |
 |
Co-Diagnostics
CODX
|
992 K | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Charles River Laboratories International
CRL
|
299 M | $ 168.44 | -3.13 % | $ 8.35 B | USA |
 |
Castle Biosciences
CSTL
|
8.14 M | $ 24.85 | 0.04 % | $ 690 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
189 M | $ 197.89 | 0.37 % | $ 22 B | USA |
 |
Danaher Corporation
DHR
|
2.49 B | $ 190.62 | -0.26 % | $ 136 B | USA |
 |
DexCom
DXCM
|
629 M | $ 62.7 | 0.76 % | $ 24.5 B | USA |
 |
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
85.9 M | $ 92.35 | -1.58 % | $ 11.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | China |
 |
ICON Public Limited Company
ICLR
|
2.3 M | $ 110.38 | -3.34 % | $ 9.1 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
1.11 M | $ 1.96 | 5.82 % | $ 8.67 M | USA |
 |
Illumina
ILMN
|
547 M | $ 127.63 | 0.2 % | $ 20.3 B | USA |
 |
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
535 M | $ 274.94 | 0.41 % | $ 22.9 B | USA |
 |
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
64.7 M | $ 76.0 | -0.14 % | $ 5.13 B | USA |
 |
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | USA |
 |
Mettler-Toledo International
MTD
|
387 M | $ 1 258.2 | -0.3 % | $ 25.9 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
30.6 M | $ 4.84 | 1.79 % | $ 448 M | USA |
 |
ENDRA Life Sciences
NDRA
|
2.62 M | $ 4.69 | - | $ 3.69 M | USA |
 |
NeoGenomics
NEO
|
28.6 M | $ 8.06 | 0.75 % | $ 1.03 B | USA |
 |
Natera
NTRA
|
35.4 M | $ 207.01 | -0.46 % | $ 20.4 B | USA |
 |
Pacific Biosciences of California
PACB
|
49.3 M | $ 1.36 | 1.49 % | $ 408 M | USA |
 |
Precipio
PRPO
|
935 K | $ 25.23 | -1.29 % | $ 40.5 M | USA |